1 Preventive Asthma Drug Market Overview 1.1 Product Overview and Scope of Preventive Asthma Drug 1.2 Preventive Asthma Drug Segment by Type 1.2.1 Global Preventive Asthma Drug Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Somatostatin Analogs 1.2.3 Targeted Therapy 1.2.4 Chemotherapy 1.3 Preventive Asthma Drug Segment by Application 1.3.1 Global Preventive Asthma Drug Sales Comparison by Application: (2021-2027) 1.3.2 Hospital 1.3.3 Clinics 1.3.4 Oncology Centres 1.4 Global Preventive Asthma Drug Market Size Estimates and Forecasts 1.4.1 Global Preventive Asthma Drug Revenue 2016-2027 1.4.2 Global Preventive Asthma Drug Sales 2016-2027 1.4.3 Preventive Asthma Drug Market Size by Region: 2016 Versus 2021 Versus 2027 2 Preventive Asthma Drug Market Competition by Manufacturers 2.1 Global Preventive Asthma Drug Sales Market Share by Manufacturers (2016-2021) 2.2 Global Preventive Asthma Drug Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Preventive Asthma Drug Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Preventive Asthma Drug Manufacturing Sites, Area Served, Product Type 2.5 Preventive Asthma Drug Market Competitive Situation and Trends 2.5.1 Preventive Asthma Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Preventive Asthma Drug Players Market Share by Revenue 2.5.3 Global Preventive Asthma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Preventive Asthma Drug Retrospective Market Scenario by Region 3.1 Global Preventive Asthma Drug Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Preventive Asthma Drug Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Preventive Asthma Drug Market Facts & Figures by Country 3.3.1 North America Preventive Asthma Drug Sales by Country 3.3.2 North America Preventive Asthma Drug Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Preventive Asthma Drug Market Facts & Figures by Country 3.4.1 Europe Preventive Asthma Drug Sales by Country 3.4.2 Europe Preventive Asthma Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Preventive Asthma Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Preventive Asthma Drug Sales by Region 3.5.2 Asia Pacific Preventive Asthma Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Preventive Asthma Drug Market Facts & Figures by Country 3.6.1 Latin America Preventive Asthma Drug Sales by Country 3.6.2 Latin America Preventive Asthma Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Preventive Asthma Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Preventive Asthma Drug Sales by Country 3.7.2 Middle East and Africa Preventive Asthma Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Preventive Asthma Drug Historic Market Analysis by Type 4.1 Global Preventive Asthma Drug Sales Market Share by Type (2016-2021) 4.2 Global Preventive Asthma Drug Revenue Market Share by Type (2016-2021) 4.3 Global Preventive Asthma Drug Price by Type (2016-2021) 5 Global Preventive Asthma Drug Historic Market Analysis by Application 5.1 Global Preventive Asthma Drug Sales Market Share by Application (2016-2021) 5.2 Global Preventive Asthma Drug Revenue Market Share by Application (2016-2021) 5.3 Global Preventive Asthma Drug Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Xiaflex 6.1.1 Xiaflex Corporation Information 6.1.2 Xiaflex Description and Business Overview 6.1.3 Xiaflex Preventive Asthma Drug Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Xiaflex Preventive Asthma Drug Product Portfolio 6.1.5 Xiaflex Recent Developments/Updates 6.2 Novartis AG 6.2.1 Novartis AG Corporation Information 6.2.2 Novartis AG Description and Business Overview 6.2.3 Novartis AG Preventive Asthma Drug Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Novartis AG Preventive Asthma Drug Product Portfolio 6.2.5 Novartis AG Recent Developments/Updates 6.3 Roche 6.3.1 Roche Corporation Information 6.3.2 Roche Description and Business Overview 6.3.3 Roche Preventive Asthma Drug Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Roche Preventive Asthma Drug Product Portfolio 6.3.5 Roche Recent Developments/Updates 6.4 Molecular Insight Pharmaceuticals 6.4.1 Molecular Insight Pharmaceuticals Corporation Information 6.4.2 Molecular Insight Pharmaceuticals Description and Business Overview 6.4.3 Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Molecular Insight Pharmaceuticals Preventive Asthma Drug Product Portfolio 6.4.5 Molecular Insight Pharmaceuticals Recent Developments/Updates 6.5 Callisto Pharmaceuticals 6.5.1 Callisto Pharmaceuticals Corporation Information 6.5.2 Callisto Pharmaceuticals Description and Business Overview 6.5.3 Callisto Pharmaceuticals Preventive Asthma Drug Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Callisto Pharmaceuticals Preventive Asthma Drug Product Portfolio 6.5.5 Callisto Pharmaceuticals Recent Developments/Updates 7 Preventive Asthma Drug Manufacturing Cost Analysis 7.1 Preventive Asthma Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Preventive Asthma Drug 7.4 Preventive Asthma Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Preventive Asthma Drug Distributors List 8.3 Preventive Asthma Drug Customers 9 Preventive Asthma Drug Market Dynamics 9.1 Preventive Asthma Drug Industry Trends 9.2 Preventive Asthma Drug Growth Drivers 9.3 Preventive Asthma Drug Market Challenges 9.4 Preventive Asthma Drug Market Restraints 10 Global Market Forecast 10.1 Preventive Asthma Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Preventive Asthma Drug by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Preventive Asthma Drug by Type (2022-2027) 10.2 Preventive Asthma Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Preventive Asthma Drug by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Preventive Asthma Drug by Application (2022-2027) 10.3 Preventive Asthma Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Preventive Asthma Drug by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Preventive Asthma Drug by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Preventive Asthma Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Preventive Asthma Drug Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Preventive Asthma Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Preventive Asthma Drug Covered in This Study Table 5. Global Preventive Asthma Drug Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Preventive Asthma Drug Sales Market Share by Manufacturers (2016-2021) Table 7. Global Preventive Asthma Drug Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Preventive Asthma Drug Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Preventive Asthma Drug Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Preventive Asthma Drug Manufacturing Sites and Area Served Table 11. Manufacturers Preventive Asthma Drug Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Preventive Asthma Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventive Asthma Drug as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Preventive Asthma Drug Sales by Region (2016-2021) & (K Units) Table 16. Global Preventive Asthma Drug Sales Market Share by Region (2016-2021) Table 17. Global Preventive Asthma Drug Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Preventive Asthma Drug Sales by Country (2016-2021) & (K Units) Table 19. North America Preventive Asthma Drug Sales Market Share by Country (2016-2021) Table 20. North America Preventive Asthma Drug Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Preventive Asthma Drug Revenue Market Share by Country (2016-2021) Table 22. Europe Preventive Asthma Drug Sales by Country (2016-2021) & (K Units) Table 23. Europe Preventive Asthma Drug Sales Market Share by Country (2016-2021) Table 24. Europe Preventive Asthma Drug Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Preventive Asthma Drug Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Preventive Asthma Drug Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Preventive Asthma Drug Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Preventive Asthma Drug Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Preventive Asthma Drug Revenue Market Share by Region (2016-2021) Table 30. Latin America Preventive Asthma Drug Sales by Country (2016-2021) & (K Units) Table 31. Latin America Preventive Asthma Drug Sales Market Share by Country (2016-2021) Table 32. Latin America Preventive Asthma Drug Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Preventive Asthma Drug Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Preventive Asthma Drug Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Preventive Asthma Drug Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Preventive Asthma Drug Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Preventive Asthma Drug Revenue Market Share by Country (2016-2021) Table 38. Global Preventive Asthma Drug Sales (K Units) by Type (2016-2021) Table 39. Global Preventive Asthma Drug Sales Market Share by Type (2016-2021) Table 40. Global Preventive Asthma Drug Revenue (Million US$) by Type (2016-2021) Table 41. Global Preventive Asthma Drug Revenue Share by Type (2016-2021) Table 42. Global Preventive Asthma Drug Price (USD/Unit) by Type (2016-2021) Table 43. Global Preventive Asthma Drug Sales (K Units) by Application (2016-2021) Table 44. Global Preventive Asthma Drug Sales Market Share by Application (2016-2021) Table 45. Global Preventive Asthma Drug Revenue (Million US$) by Application (2016-2021) Table 46. Global Preventive Asthma Drug Revenue Share by Application (2016-2021) Table 47. Global Preventive Asthma Drug Price (USD/Unit) by Application (2016-2021) Table 48. Xiaflex Corporation Information Table 49. Xiaflex Description and Business Overview Table 50. Xiaflex Preventive Asthma Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Xiaflex Preventive Asthma Drug Product Table 52. Xiaflex Recent Developments/Updates Table 53. Novartis AG Corporation Information Table 54. Novartis AG Description and Business Overview Table 55. Novartis AG Preventive Asthma Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Novartis AG Preventive Asthma Drug Product Table 57. Novartis AG Recent Developments/Updates Table 58. Roche Corporation Information Table 59. Roche Description and Business Overview Table 60. Roche Preventive Asthma Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Roche Preventive Asthma Drug Product Table 62. Roche Recent Developments/Updates Table 63. Molecular Insight Pharmaceuticals Corporation Information Table 64. Molecular Insight Pharmaceuticals Description and Business Overview Table 65. Molecular Insight Pharmaceuticals Preventive Asthma Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Molecular Insight Pharmaceuticals Preventive Asthma Drug Product Table 67. Molecular Insight Pharmaceuticals Recent Developments/Updates Table 68. Callisto Pharmaceuticals Corporation Information Table 69. Callisto Pharmaceuticals Description and Business Overview Table 70. Callisto Pharmaceuticals Preventive Asthma Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Callisto Pharmaceuticals Preventive Asthma Drug Product Table 72. Callisto Pharmaceuticals Recent Developments/Updates Table 73. Production Base and Market Concentration Rate of Raw Material Table 74. Key Suppliers of Raw Materials Table 75. Preventive Asthma Drug Distributors List Table 76. Preventive Asthma Drug Customers List Table 77. Preventive Asthma Drug Market Trends Table 78. Preventive Asthma Drug Growth Drivers Table 79. Preventive Asthma Drug Market Challenges Table 80. Preventive Asthma Drug Market Restraints Table 81. Global Preventive Asthma Drug Sales Forecast by Type (2022-2027) & (K Units) Table 82. Global Preventive Asthma Drug Sales Market Share Forecast by Type (2022-2027) Table 83. Global Preventive Asthma Drug Revenue Forecast by Type (2022-2027) & (US$ Million) Table 84. Global Preventive Asthma Drug Revenue Market Share Forecast by Type (2022-2027) Table 85. Global Preventive Asthma Drug Sales Forecast by Application (2022-2027) & (K Units) Table 86. Global Preventive Asthma Drug Sales Market Share Forecast by Application (2022-2027) Table 87. Global Preventive Asthma Drug Revenue Forecast by Application (2022-2027) & (US$ Million) Table 88. Global Preventive Asthma Drug Revenue Market Share Forecast by Application (2022-2027) Table 89. Global Preventive Asthma Drug Sales Forecast by Region (2022-2027) & (K Units) Table 90. Global Preventive Asthma Drug Sales Market Share Forecast by Region (2022-2027) Table 91. Global Preventive Asthma Drug Revenue Forecast by Region (2022-2027) & (US$ Million) Table 92. Global Preventive Asthma Drug Revenue Market Share Forecast by Region (2022-2027) Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Preventive Asthma Drug Figure 2. Global Preventive Asthma Drug Market Share by Type in 2020 & 2027 Figure 3. Somatostatin Analogs Product Picture Figure 4. Targeted Therapy Product Picture Figure 5. Chemotherapy Product Picture Figure 6. Global Preventive Asthma Drug Market Share by Application in 2020 & 2027 Figure 7. Hospital Figure 8. Clinics Figure 9. Oncology Centres Figure 10. Global Preventive Asthma Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global Preventive Asthma Drug Market Size 2016-2027 (US$ Million) Figure 12. Global Preventive Asthma Drug Sales 2016-2027 (K Units) Figure 13. Global Preventive Asthma Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 14. Preventive Asthma Drug Sales Share by Manufacturers in 2020 Figure 15. Global Preventive Asthma Drug Revenue Share by Manufacturers in 2020 Figure 16. The Global 5 and 10 Largest Preventive Asthma Drug Players: Market Share by Revenue in 2020 Figure 17. Preventive Asthma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 18. Global Preventive Asthma Drug Sales Market Share by Region (2016-2021) Figure 19. Global Preventive Asthma Drug Sales Market Share by Region in 2020 Figure 20. Global Preventive Asthma Drug Revenue Market Share by Region (2016-2021) Figure 21. Global Preventive Asthma Drug Revenue Market Share by Region in 2020 Figure 22. U.S. Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Canada Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. Germany Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. France Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. U.K. Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Italy Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Russia Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. China Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Japan Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. South Korea Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. India Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Australia Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Taiwan Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Indonesia Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Thailand Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Malaysia Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Philippines Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Vietnam Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Mexico Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Brazil Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Argentina Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Turkey Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Saudi Arabia Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. U.A.E Preventive Asthma Drug Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Sales Market Share of Preventive Asthma Drug by Type (2016-2021) Figure 47. Sales Market Share of Preventive Asthma Drug by Application (2016-2021) Figure 48. Sales Market Share of Preventive Asthma Drug by Application in 2020 Figure 49. Revenue Share of Preventive Asthma Drug by Application (2016-2021) Figure 50. Revenue Share of Preventive Asthma Drug by Application in 2020 Figure 51. Manufacturing Cost Structure of Preventive Asthma Drug Figure 52. Manufacturing Process Analysis of Preventive Asthma Drug Figure 53. Preventive Asthma Drug Industrial Chain Analysis Figure 54. Channels of Distribution Figure 55. Distributors Profiles Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Xiaflex Novartis AG Roche Molecular Insight Pharmaceuticals Callisto Pharmaceuticals